Published Date: 02 Mar 2023
Two new findings led by Cedars-Sinai researchers suggest that stem cell therapy can help speed up and speed healing of bone and muscle injuries.
Read Full NewsThe director of the Banner Sun Health Research Institute discussed a variety of meaningful Alzheimer disease research presented at the 2024 Clinical Trials on Alzheimer's Disease Conference (CTAD).
Elizabeth Gerard, MD, an epileptologist at Northwestern Medicine, provided clinical insights on a new consortium, GEAN, which aims to expand genetic testing and define adult phenotypes for rare genetic epilepsies across North America.
Angela Lek, PhD, chief research officer of the Muscular Dystrophy Association, discusses the FDA approval of intrathecal onasemnogene abeparvovec (Itvisma; Novartis) and what it means for SMA treatment across older pediatric and adult populations.
Dietary Diversity With Dairy, Fruit, Grains Linked to Lower Gout Risk
GLPG3667 Meets Primary Endpoint in Dermatomyositis, Misses in SLE Phase 3 Trials
taVNS Reduces Pain, Improves Mood in Fibromyalgia Patients
Metal Exposure Levels May Explain Cardiovascular-Kidney-Metabolic Stages
1.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
The top three drugs for multiple myeloma treatment upfront are four.
4.
Taking vitamin D daily decreased cancer mortality, according to a study.
5.
New imaging technique identifies glioblastoma patients who would benefit from immunotherapy
1.
Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer
2.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
3.
Unraveling the Mysteries of Metastasis: Exploring the Latest Advances in Cancer Research
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
The Pivotal Role of Telomerase in Breast Cancer Therapy Resistance and Treatment Strategies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
3.
Navigating the Complexities of Ph Negative ALL - Part XII
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation